![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories The prospects for a viable market in inhaled insulin therapies were looking markedly thinner this week after Eli Lilly pulled the plug on its joint development programme with drug delivery specialist Alkermes for... Read China-made heparin scare spreads beyond US The made-in-China heparin scare has now spread beyond the US, with Germany and Japan both recalling the drug as a precaution... Read Nektar optimistic despite Exubera fallout The CEO of Californian company Nektar Therapeutics says that 2007 has been key in transforming the company into a fully integrated drug development organisation, despite the setback with Pfizer's inhaled insulin... Read Eurand's formulations stack up at the FDA Drug delivery specialist Eurand could see a marked increase in revenue flow this year, both from co-development products incorporating the company's formulation technologies and a proprietary treatment addressing... Read Patheon's Q1 profits drop as it continues to address Puerto Rico Patheon's first quarter results have continued to be impacted by its underperforming Puerto Rico operations, although restructuring plans to remedy the situation are in full swing... Read |
||||||||||||||||||
All News Headlines for: March | February | January |
||||||||||||||||||
![]() Tablet Design: A Critical Aspect of Product Development Good tablet design can provide manufacturers with a unique product and helps to ensure optimum productivity, avoiding premature tooling wear and failure. For further information... Click Here | ||||||||||||||||||
Roche deal tests drug cardiotoxicity on unique lab platform Roche enters into an agreement to provide drug compounds for cardiotoxicity testing using a platform that could be used in the preclinical safety evaluation of drugs... Read Silicon tuning fork provides early detection of prion diseases A silicon tuning fork that changes pitch in the presence of deadly prions could provide an early detection of diseases such as bovine spongiform encephalopathy (BSE) and its human counterpart Creutzfeldt-Jacob... Read Galapagos loss widens in '07 as R&D escalates Galapagos has watched its loss widen over the past year as it stepped up its internal research and development activities... Read Pharmaceutical outsourcing: people on the move Patheon, Keller Crescent, Bilcare and Molecular Profiles have all had people on the move in the world of pharmaceutical outsourcing... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||